Apangu, TitusGriffith, KevinAbaru, JanetCandini, GordianApio, HarrietOkoth, FelixOkello, RobertKaggwa, JohnAcayo, SarahEzama, GeoffreyYockey, BrookSexton, ChristopherSchriefer, MartinKatongole Mbidde, EdwardMead, Paul2021-12-112021-12-112017Apangu, T., Griffith, K., Abaru, J., Candini, G., Apio, H., Okoth, F., ... & Mead, P. (2017). Successful treatment of human plague with oral ciprofloxacin. Emerging infectious diseases, 23(3), 553.http://dx.doi.org/10.1056/NEJMoa1304879http://dx.doi.org/10.1056/NEJMoa1304879.https://nru.uncst.go.ug/xmlui/handle/123456789/314The US Food and Drug Administration recently approved ciprofloxacin for treatment of plague (Yersina pestis infection) based on animal studies. Published evidence of efficacy in humans is sparse. We report 5 cases of culture-confirmed human plague treated successfully with oral ciprofloxacin, including 1 case of pneumonic plague.enTreatmentHuman PlagueOral CiprofloxacinArticle